C-reactive protein and atherothrombosis: Cause or effect?

This publication has 98 references indexed in Scilit:

• C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction
  New England Journal of Medicine, 2012
• Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study
  The Lancet, 2011
• Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo
  Atherosclerosis, 2009
• C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction
  Cardiovascular Research, 2009
• A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
  New England Journal of Medicine, 2009
• Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
  New England Journal of Medicine, 2008
• Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials
  Circulation, 2008
• C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells
  Thrombosis Research, 2008
• Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia
  Proceedings of the National Academy of Sciences, 2007
• Inflammation in atherosclerosis
  Nature, 2002